UBS Group AG 13D and 13G filings for ASLAN Pharmaceuticals Limited:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-06 10:38 am Purchase | 2024-02-06 | 13G | ASLAN Pharmaceuticals Limited ASLN | UBS Group AG | 2,114,700 8.910% | 2,114,700 (New Position) | Filing |